Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Uyenphuong H. Le, MD

LICENSE # 0101245790
 
Issue Date: 5/29/2009
Expiration Date: 5/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 5/21/2024
None Reported
Academic Appointments - Non-US
Last Updated 5/21/2024
None Reported
Publications
(up to ten in the last five years)
Last Updated 5/21/2024
Pathophysiology of rhinosinusitis: Baseline symptoms and secretions in acute sinusitis (S), allergic rhinitis (AR), the nonallergic rhinitis of Chronic Fatigue Syndrome (CFS) and normal subjects.
Am J Respir Crit Care Med.
Volume: 169
Date: 04 2004

Neuropathology in rhinosinusitis
Am J Respir Crit Care Med
Volume: 171
Date: 01 2005

The Nonallergic Rhinitis of Chronic Fatigue Syndrome
Nonallergic Rhinitis
Date: 01 2006

The nonallergic rhinitis of chronic fatigue syndrome
Clinical Allergy & Immunology
Volume: 19
Date: 12 2007

Dyspnea Without Airflow Obstruction In Chronic Fatigue Syndrome.
J Allergy and Clinical Immunology
Volume: 123
Date: 02 2009

Irritant Rhinitis Score (IRS) in Allergic (AR) and Nonallergic (NAR) Rhinitis
J Allergy and Clinical Immunology.
Volume: 123
Date: 02 2009

Ketorolac Nasal Provocation in Aspirin Sensitivity
J Allergy and Clinical Immunology
Volume: 123
Date: 02 2009

Omalizumab pretreatment does not protect against peanut oral immunotherapy-related adverse gastrointestinal events.
J Allergy Clin Immunol
Volume: 133
Date: 02 2014

Oral and sublingual immunotherapy for food allergy
WAO Journal
Volume: 7
Date: 12 2014

Successful use of palifermin following severe anaphylaxis to pegaspargase in a pediatric patient with acute lymphoblastic leukemia
J Oncol Pharm Pract
Date: 01 2015